Calton & Associates’s Sanofi SNY Stock Holding History

Calton & Associates’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-602	Closed	-$26K	–	1135
2017 Q4	$26K	Buy	+602	New	+$27.8K	0.01%	840

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Calton & Associates's SNY Position: Q1 2018 in Review

Calton & Associates sold out of Sanofi (SNY) in Q1 2018, closing a stake of 602 shares — an estimated $26K sold.

Calton & Associates first reported a position in SNY in Q4 2017 and held it in 1 quarter. The position peaked at $26K in Q4 2017. 487 funds tracked by Wall St. Rank hold SNY as of Q1 2018.

Calton & Associates reported no remaining Sanofi position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 602 Sanofi shares in Q1 2018, an estimated $26K.
Calton & Associates first reported a position in Sanofi in Q4 2017 and held it in 1 quarter.
Calton & Associates's Sanofi position peaked at $26K in Q4 2017.
487 funds tracked by Wall St. Rank held Sanofi as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.